Skip to content
Home/Companies/Biotech/SMIN Therapeutics GmbH
SMIN Therapeutics GmbH

SMIN Therapeutics GmbH

Biotech·Germany·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns SMIN Therapeutics GmbH?

SMIN Therapeutics GmbH is currently owned by BMH Beteiligungsmanagement Hessen through Technologiefonds Hessen (2007 vintage), since 2023.

Hand-verified · updated 2026-08-10

BMH Beteiligungsmanagement Hessen
Investor
BMH Beteiligungsmanagement Hessen
Technologiefonds Hessen · 2007 · VC

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.smintx.com

More from Technologiefonds Hessen

Other portfolio companies in the same fund.

Lissi GmbH
Lissi GmbH
Active
CybersecurityGermany· 2026
QuoIntelligence GmbH
Active
CybersecurityGermany· 2026
READO
Reado
Active
ConsumerGermany· 2026
Verrano GmbH
Verrano GmbH
Active
FoodTechGermany· 2026
Akribion Therapeutics GmbH
Akribion Therapeutics GmbH
Active
BiotechGermany· 2024
BIOVOX GmbH
BIOVOX GmbH
Active
MedTechGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track SMIN Therapeutics GmbH

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on SMIN Therapeutics GmbH.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue